Published in Neurology on May 10, 2005
Writing Orthotic Device for the Management of Writer's Cramp. Front Neurol (2013) 0.77
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med (2000) 6.21
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2002) 2.81
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord (1994) 2.77
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology (2006) 2.70
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
The anatomical basis of symptomatic hemidystonia. Brain (1985) 2.60
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain (2012) 2.52
Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain (1986) 2.52
Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet (1995) 2.47
Mirror movements in parkinsonism: evaluation of a new clinical sign. J Neurol Neurosurg Psychiatry (2005) 2.35
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol (1998) 2.21
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology (1998) 2.19
Prevention of osteoporosis in glucocorticoid-treated neurology patients. Clin Neurol Neurosurg (2005) 2.19
Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology (2012) 2.18
Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology (2012) 2.14
Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev (2001) 2.07
Arm levitation in progressive supranuclear palsy. Neurology (1999) 2.06
Cortical-basal ganglionic degeneration. Neurology (1990) 2.04
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Four multidetector-row helical CT: image quality and volume coverage speed. Radiology (2000) 1.92
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms. Nat Med (1997) 1.85
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology (2010) 1.79
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology (2006) 1.72
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain (2008) 1.70
Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord (1997) 1.69
Movement disorders in alcoholism: a review. Neurology (1990) 1.65
Involvement of the human pedunculopontine nucleus region in voluntary movements. Neurology (2010) 1.60
Involvement of the human subthalamic nucleus in movement preparation. Neurology (2003) 1.59
A Dehydrated Experimental Medium for the Microbiological Assay of Folic Acid. J Bacteriol (1948) 1.58
Procedural learning and neostriatal dysfunction in man. Brain (1988) 1.57
LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology (2005) 1.56
Study of physiological availability of temazepam in man. Int J Clin Pharmacol (1972) 1.49
Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord (1995) 1.48
Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology (1999) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Pallidal stimulation in cervical dystonia: clinical implications of acute changes in stimulation parameters. Eur J Neurol (2009) 1.47
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study. Neurology (2006) 1.45
A teaching videotape for the assessment of essential tremor. Mov Disord (2001) 1.45
Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease. Can J Neurol Sci (2007) 1.39
Potential benefits of dopamine striatal implant. Ann Neurol (1990) 1.38
Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology (1999) 1.36
Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn (2000) 1.35
Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J Neurophysiol (2001) 1.34
Myoclonic dystonia. Neurology (1983) 1.34
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 1.32
Simulated dose reduction in conventional chest CT: validation study. Radiology (1997) 1.32
Painful Parkinson's disease. Lancet (1986) 1.31
Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology (2005) 1.28
Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet (2000) 1.27
Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27
Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol (2001) 1.26
Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology (2001) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Helical (spiral) CT of the abdomen. AJR Am J Roentgenol (1993) 1.23
Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord (1997) 1.23
Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's disease. Brain (1999) 1.22
Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology (2001) 1.22
Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. Brain (1999) 1.21
Costing medical care: using Medicare administrative data. Med Care (1994) 1.20
High frequency of well-defined Y-chromosome deletions in idiopathic Sertoli cell-only syndrome. Hum Reprod (1998) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology (1998) 1.19
Distinct electric potentials in soma and neurite membranes. Neuron (1994) 1.19
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology (2007) 1.19
Regional cerebral glucose metabolism in SLE chorea: further evidence that striatal hypometabolism is not a correlate of chorea. Mov Disord (1987) 1.18
An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord (2000) 1.18
Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia. Neurology (2007) 1.14
Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol (1996) 1.13
A novel locus for inherited myoclonus-dystonia on 18p11. Neurology (2002) 1.13
Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Brain (2001) 1.13
Frozen shoulder and other shoulder disturbances in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.11
Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature. Mov Disord (1997) 1.11
Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat (2008) 1.10
Parkinson's disease and depression. A critical re-evaluation. Brain (1986) 1.10
Acute anticholinergic action in focal dystonia. Adv Neurol (1983) 1.09
Family history of tremor in Parkinson's disease compared with those of controls and patients with idiopathic dystonia. Adv Neurol (1987) 1.09
Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis (2013) 1.08
Hypoxic-ischemic damage of the basal ganglia. Case reports and a review of the literature. Mov Disord (1990) 1.08
Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp Brain Res (1997) 1.07
Adrenoleukomyeloneuropathy presenting as spinocerebellar degeneration. Neurology (1982) 1.07
Secondary dystonia. Adv Neurol (1988) 1.07
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol (1995) 1.06
Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology (1998) 1.05
Deep brain stimulator electrodes used for lesioning: proof of principle. Neurosurgery (2001) 1.05
Memory and learning in early Parkinson's disease: evidence for a "frontal lobe syndrome". Brain Cogn (1990) 1.05